1. Billiau, A., de Somer, P.: Clinical use of interferons in viral infections. In:Stringfellow, D. A. (ed.), Interferon and Interferon Inducers, Clinical Applications, 113?144. New York-Basel: Marcel Dekker 1980.
2. Billiau, A., de Somer, P., Edy, V. G., de Clercq, E., Heremans, H.: Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans. Antimicrob. Agents Chemother.16, 53?63 (1979).
3. Billiau, A., van Damme, J., van Leuven, F., Edy, V. G., de Ley, M., Cassiman, J. J., van den Berghe, H., de Somer, P.: Human fibroblast interferon for clinical trials: production, partial purification, and characterization. Antimicrob. Agents Chemother.16, 49?55 (1979).
4. Edy, V. G., Billiau, A., de Somer, P.: Non-appearance of injected fibroblast interferon in the circulation. Lanceti, 451?452 (1978).
5. Finter, N B.: Dye uptake methods for assessing viral cytopathogenicity and their application to interferon assays. J. gen. Virol.5, 419?427 (1969).